Katsuta, E., Yan, L., Takeshita, T., McDonald, K., Dasgupta, S., Opyrchal, M., & Takabe, K. (2019). High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer. Int J Mol Sci.
Chicago-stil citatKatsuta, Eriko, Li Yan, Takashi Takeshita, Kerry-Ann McDonald, Subhamoy Dasgupta, Mateusz Opyrchal, och Kazuaki Takabe. "High MYC MRNA Expression Is More Clinically Relevant Than MYC DNA Amplification in Triple-Negative Breast Cancer." Int J Mol Sci 2019.
MLA-referensKatsuta, Eriko, et al. "High MYC MRNA Expression Is More Clinically Relevant Than MYC DNA Amplification in Triple-Negative Breast Cancer." Int J Mol Sci 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.